L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome
NCT01603446
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
MELAS Syndrome
Interventions
DRUG:
L-Arginine
Sponsor
The Hospital for Sick Children